Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336293 · ClinicalTrials.gov registry record · NA
sTMS for Substance Use-disordered Veterans
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04336293: Completed NA study, sponsored by VA Office of Research and Development.
NCT04336293 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04336293, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if synchronized transcranial magnetic stimulation is safe and tolerable in individuals with cocaine, opioid, or alcohol use disorders.
Interventions
- DEVICE sTMS
- DEVICE sham sTMS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-09-07 |
| Est. Completion | 2023-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04336293
The ClinicalTrials.gov registry entry for NCT04336293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sTMS is the first listed.
NCT04336293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04336293 about?
NCT04336293 is a clinical study titled "sTMS for Substance Use-disordered Veterans". The purpose of this study is to determine if synchronized transcranial magnetic stimulation is safe and tolerable in individuals with cocaine, opioid, or alcohol use disorders.
What is the current status of trial NCT04336293?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-09-07. Estimated completion is 2023-12-29.
What interventions are being tested in trial NCT04336293?
The interventions under investigation include: sTMS (DEVICE), sham sTMS (DEVICE).
Who is sponsoring clinical trial NCT04336293?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.